North American Ash on Brink of Extinction

The latest IUCN Red List update also reveals substantial declines in antelopes and other species, but some level of recovery in populations of snow leopards.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The white ash, Fraxinus americana, is listed as critically endangered by the IUCN.WIKIMEDIA, RICHARD WEBBThe latest version of the International Union for Conversation of Nature (IUCN) Red List reveals that while protection efforts appear to be slowing population declines of some threatened organisms, many others species, from antelopes to millipedes, are facing serious declines. Of the 87,967 species cited in the update yesterday (September 14), more than 25,000 are nearing extinction.

Populations of North America’s ash trees are in dramatic decline as a result of infections with invasive emerald ash borer beetles, with all but one the continent’s six species reclassified as critically endangered—one category away from extinction. “Ash trees are essential to plant communities of the United States and have been a popular horticultural species,” Murphy Westwood, a member of the IUCN Global Tree Specialist Group who led the assessment, says in a statement. “Their decline, which is likely to affect over 80 percent of the trees, will dramatically change the composition of both wild and urban forests.”

Meanwhile, the Christmas Island pipistrelle, a bat endemic to the Australian territory, has now been officially declared extinct. “It’s very difficult to decide when a species definitely ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies